Miami Beach billionaire Dr. Phillip Frost was the lead investor in the $5 million stock offering of New York-based Actinium Pharmaceuticals.

The company (NYSE: ATNM) said it signed subscription agreements with certain investors to issue 1.92 million shares at $2.60 each, with Frost leading the financing. It didn’t say exactly how many shares Frost would purchase. The deal should close on June 10.

Source: www.bizjournals.com